From exposure to air pollution to frequent pregnancies, known the lesser-known causes that can lead to anemia.

Although not guideline-approved, screening for iron deficiency in patients with risk factors could prevent progression to ...

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

Targeting Transformative Solutions for Aplastic Anemia and BeyondSAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: ...

A recent case study described a K-negative pregnant patient who was successfully treated with therapeutic plasma exchange and ...

At the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) annual meeting, Michael Hehir, MD, of the ...

Analyst Eric Joseph of J.P. Morgan maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the price target of ...

Severe side effects were reported in 65% of patients, with neutropenia, pneumonia, and anemia being common. Fixed-duration ...

In mice, dampening the activity of area postrema neurons diminished cancer-induced muscle and fat loss and increased lifespan ...

The guidelines call for a triple immunosuppression treatment regimen for LN ... hypertension, diarrhea, headache, anemia, cough, urinary tract infection, abdominal pain upper, dyspepsia, alopecia, ...

It reported the medication was effective at increasing the rate of growth by 2.5cm a year for up to 18 months during treatment, increasing overall height and improving the upper-to-lower-body segment ...

A recent study found that a non-invasive test based on carbon monoxide could help diagnose HDFN earlier and improve outcomes.